1©2020 Innopharma Technology Ltd.
The Value of Real-time Imaging:
Integrating Particle Size Analysis
onto Fluid Beds, Twin Screw
Granulators and Roller
Compactors
Darren McHugh & Chris O’Callaghan – Innopharma Technology
2020-03-24
2
Overview
• Innopharma Introduction
• Eyecon2 – Direct Imaging System for In-line
Particle Size Measurement
• Practical Considerationsfor Implementation
• or Interface with Process Equipment
• Application
• TSG, Milling, FBG
• Deep Dive – Wuster Coating the Real-Time
Prediction of Polymer-Coated Multiparticulate
Dissolution.
• Review
• Q&A
©2020,Innopharma TechnologyLtd
3
InnopharmaCompany Background
• Founded in 2009
• Three divisions:
• Education & Upskilling
• Technology to Enable Advanced Manufacturing/Process Analytical Technology
• Technical Services
• Currently ~60 employees experienced in STEM, Pharma development and
manufacturing operations, IT & Software Development
©2020,Innopharma TechnologyLtd
4
InnopharmaTechnology - Our Products
• Functional insight and control
• Integration and storage of all process
• Analytical data in a single, easy access view
• Pre-configuration of experimental and DoE
• Higher resolution of in-process data
• Understanding of design space
• Scale up control to commercial manufacturing
Direct Imaging Particle Analyser Multi-point NIR Spectrometer Vertically integrated platform for Smart
Process development and Manufacture
• Near infrared spectrophotometer for measuring
changes in process in real-time, in-line
• Highly effective in monitoring moisture content
from 0 to 27 ± 0.8%.
• Analyse component concentrations and
material density
• User Friendly chemometrics package included
– Quanta Model Developer™
• Particle analyser for powders and bulk solids
• Detect Fluid bed Pellet (Wurster) Coating
Thickness.
• Determine why a process is failing or reducing
yield in-line
• Capture manufacturing consistency automatically
• Particle size and shape analysis software
EyePASS™ included
5
PAT, Sensorsand Platforms forAdvancedManufacturing
2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Sensors
Development of sensors for solids processing
Eyecon in-line real time PSD
Eyecon2 second generation PSD
Multieye in-line real time NIR
Multieye2 second generation NIR
Advanced Manufacturing - Pharma 4.0
R&D IIOT platform for dev & manufacturing
SmartX for fluid bed granulation / coating
SmartX for crystallisation
SmartX for twin screw granulation
Started
Ongoing
Completed
Journey of PAT, Sensors &Advanced ManufacturingPlatforms
©2020,Innopharma TechnologyLtd
6
Particle SizeAnalyser: Eyecon2
• Real-Time particle Size Distribution and shape
• Use in:
• Research & development
(QbD/DoE/CPP/CQA)
• Scale up
• Tech transfer
• Manufacturing
• Batch
• Continuous
• Use on:
• Fluidised Bed Coating,
Granulation, Drying
• Twin Screw Granulation
• Roller Compaction/Milling
• Extrusion, Spheronisation
©2020,Innopharma TechnologyLtd
7
Eyecon2 Technical Specifications
©2020,Innopharma TechnologyLtd
Size Range 50 to 5500 µm
Casing materials 304 Stainless Steel, Glass, Silicon (gaskets)
Imaging Area 11.25 x 11.25 mm
Output PDF session report. CSV, full PSD from
D5-D95. JPEG (images)
Instrument Ratings GMP Compliant Design
EyePASS is both 21 CFR part 11 & GAMP5
Compliant
CE Marking
ATEX zones 2/22, IP65.
Configurations In-line and at/offline
Communication Ethernet and USB
OPC UA, OPC DA 3.0
8
Device Overview Video
©2020,Innopharma TechnologyLtd
9
Benchtop
©2020,Innopharma TechnologyLtd
10
Inline
©2020,Innopharma TechnologyLtd
11
Method of Operation: Image Capture
• A flash-imaging technique is used with an extremely short light-pulse to illuminate
moving particles for image capture
• Red, Green and Blue LEDs illuminating the sample from different angles for accurate
detection of particle boundaries
©2020,Innopharma TechnologyLtd
12
Method of Operation: Image Analysis
©2020,Innopharma TechnologyLtd
• Each particle initially identified
• Best-fit ellipse calculated
• Major & minor diameters
computed
• PSD/D-values determined
13
Particle Size
• The D-values are computed from the group
of ellipses estimated from the particles
• D50 value, also known as mass-median-
diameter (MMD) is the diameter which
divides the particles into two groups with
equivalent weight / mass.
• Similarly, the mass of particles with diameters
smaller than D10, D50, D90 equals to 10%,
50%, 90% of the total mass
©2020,Innopharma TechnologyLtd
D10
10 % Weight 90 % Weight
D50
Weight Weight=
14
Eyecon2 Data Output
©2020,Innopharma TechnologyLtd
15
Geometry of Illumination
©2020,Innopharma TechnologyLtd
16
Geometry of Illumination
©2020,Innopharma TechnologyLtd
17
IlluminationCalculator
©2020,Innopharma TechnologyLtd
18
PresentingParticles forImaging: 1
• Particles imaged directly behind surface of window
• Applicable with quasi-static bodies of material e.g. fluid
bed, and with flowing materials
• Window helps to ensure particles are optimally
presented within the depth of field
Challenges
• Wide PSD – smaller particles obscure larger
• Differential particle speeds & bouncing – angle
• Fouling of window
• Agglomeration – sticking or static
©2020,Innopharma TechnologyLtd
19
PresentingParticles forImaging: 2
• Particles imaged flowing between window & chute
(typically stainless steel)
• Applicable only to flowing material
• Useful with wetter / stickier materials as backing
surface can have greater resistance to fouling than
window
Challenges
• Constraining flow within degrees of freedom while
minimising risk of blocking
• Differential particle speeds & bouncing – angle
• Fouling of window & backing surface – accessibility for
clearing fouling & blockages
©2020,Innopharma TechnologyLtd
20
Equipment Integration Solutions
• What to consider
• Presentation
• Representation
• Maintain consistent presentation of material
• For FB position below material bed level
• For TSG image onto backing surface
• Maximise number of particles captured per
image
• Optimise positioning in focal plane
• Minimise fouling
©2020,Innopharma TechnologyLtd
21
FluidBed Interfaces
©2020,Innopharma TechnologyLtd
Lab Pilot Manufacturing
22
InterfaceExamples
©2020,Innopharma TechnologyLtd
Develop Scale Up Manufacturing
Twin-Screw
Granulation
Milling
Drier
Outlet
Roller
Compaction
Dev. Scale Conti.
Line
Filling
23
Fouling
• Fouling Control
• Prevent the ingress of the fouling material
• Low-fouling surfaces (for example, very
smooth, implanted with ions, or of low surface
energy like Teflon) are an option for some
applications.
• Anti-static
• Sapphire (Low coefficient of friction)
• Purge valves
• The conditioning of the glass and its orientation
©2020,Innopharma TechnologyLtd
24
FoulingControl
©2020,Innopharma TechnologyLtd
Issue Solution Issue Solution
25©2020 Innopharma Technology Ltd. Confidential
Eyecon2 In-LineApplication Examples
Chris O’Callaghan, Head of Engineering
ocallaghanc@innopharmalabs.com
26
Twin-Screw WetGranulation
• Continuous granulation – measurement of
wet particles directly at outlet
• Polished, heated chute to reduce sticking
• Quick DoEs: 5~7 minutes per experiment
• No stops between experiments
• No time required for sampling, drying,
offline analysis
• Start-up dynamics and atypical runs rapidly
& clearly identifiable
©2020,Innopharma TechnologyLtd
0
200
400
600
800
1000
1200
1400
1600
1800
2000
0:00:00 0:01:26 0:02:53 0:04:19
particlesizeDv50(µm)
time
2
3
throughput
(kg/h)
u = 500 rpm
xL/S = 20 %
T = 20 °C
27
Milling
• HME, pelletisation and milling DoE (HosokawaAlpine 100)
• Varied mesh size and RPM
• Aim to determine optimum parameter setpoints to
minimise risk of O.O.S. material
• Eyecon integrated directly after Mill outlet
• Measured impact of parameter changes and process
fluctuations in real time
©2020,Innopharma TechnologyLtd
0
50
100
150
200
250
ParticleSize(µm)
Process Run Time
Process Profile - 1 mm Mesh
D_v50_4 D_v50_5 D_v50_6 Lim_Low Lim_Up
0
100
200
300
400
1 2 3 4 5 6 7 8 9 10 11
ParticleSize(µm)
Experiment No.
PSD & Range by Experiment Number
D_v10 D_v50 D_v90
28
FluidBed Granulation
• Automation of a fluid bed wet granulation process using
Innopharma’s SmartX advanced control platform
• Eyecon2 provided real-time particle measurement used for phase
end-point determination – greater control of end-product quality
• Subsequent study in progress on linking inlet velocity to real-time
particle size to optimise between fluidising & transport velocities
©2020,Innopharma TechnologyLtd
29
Application Deep Dive: WursterCoating
• Dissolution Prediction Example published in Pharmaceutical
Technology April 2017 issue, Pharma Focus Asia Issue 33,
presented at IFPAC 2017
©2020,Innopharma TechnologyLtd
30
Modified Release Products
• Formulations where the in-vitro release time or location of the drug are engineered to
meet therapeutic objectives
• Release location
• Patient convenience
• Controlled release / sustained release / delayed release…
• In oral solid dosage forms typically accomplished with functional coating on tablet /
minitablets / pellets
©2020,Innopharma TechnologyLtd
31
The WursterCoating Process
©2020,Innopharma TechnologyLtd
32
Control of Coating Processes
• Current methods use little to no inline CQA
monitoring
• Typically controlled by spraying a fixed quantity of
coating factor
• Coating is an additive process - as coating is
applied a particle size increase is expected
• Directly related to weight gain
• Size increase -> film thickness -> predictor of
dissolution performance
©2020,Innopharma TechnologyLtd
33
PresentingParticles forImaging: 1
• Particles imaged directly behind surface of window
• Applicable with quasi-static bodies of material e.g.
fluid bed, and with flowing materials
• Window helps to ensure particles are optimally
presented within the depth of field
• Challenges
• Wide PSD – smaller particles obscure larger
• Differential particle speeds & bouncing – angle
• Fouling of window
• Agglomeration – sticking or static
©2020,Innopharma TechnologyLtd
34
Dissolution Prediction Study: Equipment & Formulation
Material Amount/batch
CPM layered Sugar Spheres (12 mg) - 18/20 mesh 2000 g
Surelease – aqueous ethylcellulose dispersion 1408 g
Opadry Clear 88 g
DI Water 1437 g
©2020,Innopharma TechnologyLtd
Batch
Size
(kg)
Inlet Air
Temp
(oC)
Product
Temp
(oC)
Spray
Rate
(g/min)
Air Volume
(CMH)
Atm
Air
(bar)
Orifice
Plate
Partition
Ht.
(mm)
2 70-75 44-46 15-20 100 – 110 1.6 B 30
• Glatt GPCG2 with 7” expansion chamber extension
• 6” PAT-compatible Wursterproduct container Fitted with Eyecon2
35
DOE & Sampling Strategy
• Duplicate experiments conducted
• CPM-SR-1 – develop basic model
• CPM-SR-2 – validate basic model
& improve
• Coated to 20% weight gain
• Samples taken at 2.5% w.g. intervals
• Additional samples after 30 & 60
minutes curing time
• Offline analysis
• Camsizer
• Dissolution testing
©2020,Innopharma TechnologyLtd
36
0
5
10
15
20
25
30
35
40
0.0% 5.0% 10.0% 15.0% 20.0% 25.0%
FilmThickness(µm)
Sample Point/ % Weight Gain Predicted
Film thickness (µm) as a factor of predicted weight gain
percentage - Batch 1
In-LinePSD during WursterCoating: FilmThickness
• Observable, consistent growth between sample points
©2020,Innopharma TechnologyLtd
d
d + 2 f
37
At-Line– In-LinePSD Validation
• R2 = 0.9895
• Strong correlation between Eyecon & Camsizer
©2020,Innopharma TechnologyLtd
y = 0.9404x+ 95.628
R² = 0.9895
800
850
900
950
1000
1050
1100
800 850 900 950 1000 1050
ParticleSize(diameter,µm)-Eyecon
Particle Size (diameter, um) - Camsizer
Eyecon vs. Camsizer - Combined Particle Size Ranges
D50 Linear (D50)
38
In-LinePSD during WursterCoating: Dissolution Data
0
20
40
60
80
100
120
0 60 120 180 240 300 360 420 480 540 600 660 720
%Dissolved
Time in DissolutionMedium (minutes)
Dissolution Data Grouped by Time Point – Batch 1
CPM-SR-5% CPM-SR-10% CPM-SR-15% CPM-SR-20% CPM-SR-20%-30 min CPM-SR-20%-1 hr
©2020,Innopharma TechnologyLtd
39
y = -0.0235x2
- 0.2502x+ 101.83
R² = 0.9987
0
20
40
60
80
100
120
0 10 20 30 40 50
Dissolution%
Film Thickness (µm)
Film Thickness vs. Dissolution – Batch 1
Film Thickness vs Dissolution @120 minutes
In-LinePSD during WursterCoating:
Relationship Between Dissolution& FilmThickness
• Polynomial fit between PSD & dissolution for varying film thickness
• Shows possibility of model-based real-time measurement / prediction of dissolution!
©2020,Innopharma TechnologyLtd
40
In-LinePSD during WursterCoating:
Predicted Dissolutionvs Actual
0%
20%
40%
60%
80%
100%
120%
0 100 200 300 400 500 600 700 800
Dissolution%
Time (minutes)
Batch 2: Predicted vs Actual Results
5% WG (P)
10% WG (P)
15% WG (P)
20% WG (P)
30 min cured (P)
60 min cured (P)
5% WG (A)
10% WG (A)
15% WG (A)
20% WG (A)
30 min cured (A)
60 min cured (A)
©2020,Innopharma TechnologyLtd
41
Review
• Innopharma Introduction
• Eyecon2 – Direct Imaging System for In-line
Particle Size Measurement
• Practical Considerations for Implementation
• Sensor Interface with Process Equipment
• Application
• TSG, Milling, FBG
• Deep Dive – Wuster Coating the Real-Time
Prediction of Polymer-Coated
Multiparticulate Dissolution.
©2020,Innopharma TechnologyLtd
42
Thank you!
Thank you for listening!
Questions?
©2020,Innopharma TechnologyLtd
Darren McHugh
Product Manager
Innopharma Technology Ltd
mchughd@innopharmalabs.com
Chris O’Callaghan
Head of Engineering
Innopharma Technology Ltd
ocallaghanc@innopharmalabs.com

The Value of Real-time Imaging: Integrating Particle Size Analysis onto Fluid Beds, Twin Screw Granulators and Roller Compactors

  • 1.
    1©2020 Innopharma TechnologyLtd. The Value of Real-time Imaging: Integrating Particle Size Analysis onto Fluid Beds, Twin Screw Granulators and Roller Compactors Darren McHugh & Chris O’Callaghan – Innopharma Technology 2020-03-24
  • 2.
    2 Overview • Innopharma Introduction •Eyecon2 – Direct Imaging System for In-line Particle Size Measurement • Practical Considerationsfor Implementation • or Interface with Process Equipment • Application • TSG, Milling, FBG • Deep Dive – Wuster Coating the Real-Time Prediction of Polymer-Coated Multiparticulate Dissolution. • Review • Q&A ©2020,Innopharma TechnologyLtd
  • 3.
    3 InnopharmaCompany Background • Foundedin 2009 • Three divisions: • Education & Upskilling • Technology to Enable Advanced Manufacturing/Process Analytical Technology • Technical Services • Currently ~60 employees experienced in STEM, Pharma development and manufacturing operations, IT & Software Development ©2020,Innopharma TechnologyLtd
  • 4.
    4 InnopharmaTechnology - OurProducts • Functional insight and control • Integration and storage of all process • Analytical data in a single, easy access view • Pre-configuration of experimental and DoE • Higher resolution of in-process data • Understanding of design space • Scale up control to commercial manufacturing Direct Imaging Particle Analyser Multi-point NIR Spectrometer Vertically integrated platform for Smart Process development and Manufacture • Near infrared spectrophotometer for measuring changes in process in real-time, in-line • Highly effective in monitoring moisture content from 0 to 27 ± 0.8%. • Analyse component concentrations and material density • User Friendly chemometrics package included – Quanta Model Developer™ • Particle analyser for powders and bulk solids • Detect Fluid bed Pellet (Wurster) Coating Thickness. • Determine why a process is failing or reducing yield in-line • Capture manufacturing consistency automatically • Particle size and shape analysis software EyePASS™ included
  • 5.
    5 PAT, Sensorsand PlatformsforAdvancedManufacturing 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Sensors Development of sensors for solids processing Eyecon in-line real time PSD Eyecon2 second generation PSD Multieye in-line real time NIR Multieye2 second generation NIR Advanced Manufacturing - Pharma 4.0 R&D IIOT platform for dev & manufacturing SmartX for fluid bed granulation / coating SmartX for crystallisation SmartX for twin screw granulation Started Ongoing Completed Journey of PAT, Sensors &Advanced ManufacturingPlatforms ©2020,Innopharma TechnologyLtd
  • 6.
    6 Particle SizeAnalyser: Eyecon2 •Real-Time particle Size Distribution and shape • Use in: • Research & development (QbD/DoE/CPP/CQA) • Scale up • Tech transfer • Manufacturing • Batch • Continuous • Use on: • Fluidised Bed Coating, Granulation, Drying • Twin Screw Granulation • Roller Compaction/Milling • Extrusion, Spheronisation ©2020,Innopharma TechnologyLtd
  • 7.
    7 Eyecon2 Technical Specifications ©2020,InnopharmaTechnologyLtd Size Range 50 to 5500 µm Casing materials 304 Stainless Steel, Glass, Silicon (gaskets) Imaging Area 11.25 x 11.25 mm Output PDF session report. CSV, full PSD from D5-D95. JPEG (images) Instrument Ratings GMP Compliant Design EyePASS is both 21 CFR part 11 & GAMP5 Compliant CE Marking ATEX zones 2/22, IP65. Configurations In-line and at/offline Communication Ethernet and USB OPC UA, OPC DA 3.0
  • 8.
  • 9.
  • 10.
  • 11.
    11 Method of Operation:Image Capture • A flash-imaging technique is used with an extremely short light-pulse to illuminate moving particles for image capture • Red, Green and Blue LEDs illuminating the sample from different angles for accurate detection of particle boundaries ©2020,Innopharma TechnologyLtd
  • 12.
    12 Method of Operation:Image Analysis ©2020,Innopharma TechnologyLtd • Each particle initially identified • Best-fit ellipse calculated • Major & minor diameters computed • PSD/D-values determined
  • 13.
    13 Particle Size • TheD-values are computed from the group of ellipses estimated from the particles • D50 value, also known as mass-median- diameter (MMD) is the diameter which divides the particles into two groups with equivalent weight / mass. • Similarly, the mass of particles with diameters smaller than D10, D50, D90 equals to 10%, 50%, 90% of the total mass ©2020,Innopharma TechnologyLtd D10 10 % Weight 90 % Weight D50 Weight Weight=
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
    18 PresentingParticles forImaging: 1 •Particles imaged directly behind surface of window • Applicable with quasi-static bodies of material e.g. fluid bed, and with flowing materials • Window helps to ensure particles are optimally presented within the depth of field Challenges • Wide PSD – smaller particles obscure larger • Differential particle speeds & bouncing – angle • Fouling of window • Agglomeration – sticking or static ©2020,Innopharma TechnologyLtd
  • 19.
    19 PresentingParticles forImaging: 2 •Particles imaged flowing between window & chute (typically stainless steel) • Applicable only to flowing material • Useful with wetter / stickier materials as backing surface can have greater resistance to fouling than window Challenges • Constraining flow within degrees of freedom while minimising risk of blocking • Differential particle speeds & bouncing – angle • Fouling of window & backing surface – accessibility for clearing fouling & blockages ©2020,Innopharma TechnologyLtd
  • 20.
    20 Equipment Integration Solutions •What to consider • Presentation • Representation • Maintain consistent presentation of material • For FB position below material bed level • For TSG image onto backing surface • Maximise number of particles captured per image • Optimise positioning in focal plane • Minimise fouling ©2020,Innopharma TechnologyLtd
  • 21.
  • 22.
    22 InterfaceExamples ©2020,Innopharma TechnologyLtd Develop ScaleUp Manufacturing Twin-Screw Granulation Milling Drier Outlet Roller Compaction Dev. Scale Conti. Line Filling
  • 23.
    23 Fouling • Fouling Control •Prevent the ingress of the fouling material • Low-fouling surfaces (for example, very smooth, implanted with ions, or of low surface energy like Teflon) are an option for some applications. • Anti-static • Sapphire (Low coefficient of friction) • Purge valves • The conditioning of the glass and its orientation ©2020,Innopharma TechnologyLtd
  • 24.
  • 25.
    25©2020 Innopharma TechnologyLtd. Confidential Eyecon2 In-LineApplication Examples Chris O’Callaghan, Head of Engineering ocallaghanc@innopharmalabs.com
  • 26.
    26 Twin-Screw WetGranulation • Continuousgranulation – measurement of wet particles directly at outlet • Polished, heated chute to reduce sticking • Quick DoEs: 5~7 minutes per experiment • No stops between experiments • No time required for sampling, drying, offline analysis • Start-up dynamics and atypical runs rapidly & clearly identifiable ©2020,Innopharma TechnologyLtd 0 200 400 600 800 1000 1200 1400 1600 1800 2000 0:00:00 0:01:26 0:02:53 0:04:19 particlesizeDv50(µm) time 2 3 throughput (kg/h) u = 500 rpm xL/S = 20 % T = 20 °C
  • 27.
    27 Milling • HME, pelletisationand milling DoE (HosokawaAlpine 100) • Varied mesh size and RPM • Aim to determine optimum parameter setpoints to minimise risk of O.O.S. material • Eyecon integrated directly after Mill outlet • Measured impact of parameter changes and process fluctuations in real time ©2020,Innopharma TechnologyLtd 0 50 100 150 200 250 ParticleSize(µm) Process Run Time Process Profile - 1 mm Mesh D_v50_4 D_v50_5 D_v50_6 Lim_Low Lim_Up 0 100 200 300 400 1 2 3 4 5 6 7 8 9 10 11 ParticleSize(µm) Experiment No. PSD & Range by Experiment Number D_v10 D_v50 D_v90
  • 28.
    28 FluidBed Granulation • Automationof a fluid bed wet granulation process using Innopharma’s SmartX advanced control platform • Eyecon2 provided real-time particle measurement used for phase end-point determination – greater control of end-product quality • Subsequent study in progress on linking inlet velocity to real-time particle size to optimise between fluidising & transport velocities ©2020,Innopharma TechnologyLtd
  • 29.
    29 Application Deep Dive:WursterCoating • Dissolution Prediction Example published in Pharmaceutical Technology April 2017 issue, Pharma Focus Asia Issue 33, presented at IFPAC 2017 ©2020,Innopharma TechnologyLtd
  • 30.
    30 Modified Release Products •Formulations where the in-vitro release time or location of the drug are engineered to meet therapeutic objectives • Release location • Patient convenience • Controlled release / sustained release / delayed release… • In oral solid dosage forms typically accomplished with functional coating on tablet / minitablets / pellets ©2020,Innopharma TechnologyLtd
  • 31.
  • 32.
    32 Control of CoatingProcesses • Current methods use little to no inline CQA monitoring • Typically controlled by spraying a fixed quantity of coating factor • Coating is an additive process - as coating is applied a particle size increase is expected • Directly related to weight gain • Size increase -> film thickness -> predictor of dissolution performance ©2020,Innopharma TechnologyLtd
  • 33.
    33 PresentingParticles forImaging: 1 •Particles imaged directly behind surface of window • Applicable with quasi-static bodies of material e.g. fluid bed, and with flowing materials • Window helps to ensure particles are optimally presented within the depth of field • Challenges • Wide PSD – smaller particles obscure larger • Differential particle speeds & bouncing – angle • Fouling of window • Agglomeration – sticking or static ©2020,Innopharma TechnologyLtd
  • 34.
    34 Dissolution Prediction Study:Equipment & Formulation Material Amount/batch CPM layered Sugar Spheres (12 mg) - 18/20 mesh 2000 g Surelease – aqueous ethylcellulose dispersion 1408 g Opadry Clear 88 g DI Water 1437 g ©2020,Innopharma TechnologyLtd Batch Size (kg) Inlet Air Temp (oC) Product Temp (oC) Spray Rate (g/min) Air Volume (CMH) Atm Air (bar) Orifice Plate Partition Ht. (mm) 2 70-75 44-46 15-20 100 – 110 1.6 B 30 • Glatt GPCG2 with 7” expansion chamber extension • 6” PAT-compatible Wursterproduct container Fitted with Eyecon2
  • 35.
    35 DOE & SamplingStrategy • Duplicate experiments conducted • CPM-SR-1 – develop basic model • CPM-SR-2 – validate basic model & improve • Coated to 20% weight gain • Samples taken at 2.5% w.g. intervals • Additional samples after 30 & 60 minutes curing time • Offline analysis • Camsizer • Dissolution testing ©2020,Innopharma TechnologyLtd
  • 36.
    36 0 5 10 15 20 25 30 35 40 0.0% 5.0% 10.0%15.0% 20.0% 25.0% FilmThickness(µm) Sample Point/ % Weight Gain Predicted Film thickness (µm) as a factor of predicted weight gain percentage - Batch 1 In-LinePSD during WursterCoating: FilmThickness • Observable, consistent growth between sample points ©2020,Innopharma TechnologyLtd d d + 2 f
  • 37.
    37 At-Line– In-LinePSD Validation •R2 = 0.9895 • Strong correlation between Eyecon & Camsizer ©2020,Innopharma TechnologyLtd y = 0.9404x+ 95.628 R² = 0.9895 800 850 900 950 1000 1050 1100 800 850 900 950 1000 1050 ParticleSize(diameter,µm)-Eyecon Particle Size (diameter, um) - Camsizer Eyecon vs. Camsizer - Combined Particle Size Ranges D50 Linear (D50)
  • 38.
    38 In-LinePSD during WursterCoating:Dissolution Data 0 20 40 60 80 100 120 0 60 120 180 240 300 360 420 480 540 600 660 720 %Dissolved Time in DissolutionMedium (minutes) Dissolution Data Grouped by Time Point – Batch 1 CPM-SR-5% CPM-SR-10% CPM-SR-15% CPM-SR-20% CPM-SR-20%-30 min CPM-SR-20%-1 hr ©2020,Innopharma TechnologyLtd
  • 39.
    39 y = -0.0235x2 -0.2502x+ 101.83 R² = 0.9987 0 20 40 60 80 100 120 0 10 20 30 40 50 Dissolution% Film Thickness (µm) Film Thickness vs. Dissolution – Batch 1 Film Thickness vs Dissolution @120 minutes In-LinePSD during WursterCoating: Relationship Between Dissolution& FilmThickness • Polynomial fit between PSD & dissolution for varying film thickness • Shows possibility of model-based real-time measurement / prediction of dissolution! ©2020,Innopharma TechnologyLtd
  • 40.
    40 In-LinePSD during WursterCoating: PredictedDissolutionvs Actual 0% 20% 40% 60% 80% 100% 120% 0 100 200 300 400 500 600 700 800 Dissolution% Time (minutes) Batch 2: Predicted vs Actual Results 5% WG (P) 10% WG (P) 15% WG (P) 20% WG (P) 30 min cured (P) 60 min cured (P) 5% WG (A) 10% WG (A) 15% WG (A) 20% WG (A) 30 min cured (A) 60 min cured (A) ©2020,Innopharma TechnologyLtd
  • 41.
    41 Review • Innopharma Introduction •Eyecon2 – Direct Imaging System for In-line Particle Size Measurement • Practical Considerations for Implementation • Sensor Interface with Process Equipment • Application • TSG, Milling, FBG • Deep Dive – Wuster Coating the Real-Time Prediction of Polymer-Coated Multiparticulate Dissolution. ©2020,Innopharma TechnologyLtd
  • 42.
    42 Thank you! Thank youfor listening! Questions? ©2020,Innopharma TechnologyLtd Darren McHugh Product Manager Innopharma Technology Ltd mchughd@innopharmalabs.com Chris O’Callaghan Head of Engineering Innopharma Technology Ltd ocallaghanc@innopharmalabs.com